acebutolol has been researched along with Cancer of Parotid in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigorre, M | 1 |
| Van Kien, AK | 1 |
| Valette, H | 1 |
1 other study available for acebutolol and Cancer of Parotid
| Article | Year |
|---|---|
Beta-blocking agent for treatment of infantile hemangioma.
Topics: Acebutolol; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Hemangioma; Humans; Infant; Male; | 2009 |